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Objective: Conventional extracorporeal circulation results in an activation of coag-
ulation cascades. Coating of extracorporeal circulation tubes as well as avoidance of
shed blood recirculation have been shown to reduce these phenomena. We evaluated
a new shed blood separation system (AVANT D 970) utilizing a coated cardiopul-
monary bypass tube system (PHISIO).
Methods: Forty patients (62 10 years) underwent isolated coronary revascularization.
Four groups (n  10/group) were defined: no extracorporeal circulation, conventional
uncoated extracorporeal circulation, uncoated extracorporeal circulation with shed blood
separation, and coated extracorporeal circulation with shed blood separation. Thrombin-
antithrombin complex and free Hb were analyzed and statistically compared.
Results: Conventional extracorporeal circulation exhibited the highest intraoperative
activation of coagulation (thrombin-antithrombin complex: extracorporeal circula-
tion, 31.1  15.8 g/L; uncoated extracorporeal circulation with shed blood
separation, 15.3  7.8 g/L; coated extracorporeal circulation with shed blood
separation, 8.1  4.8 g/L; no extracorporeal circulation, 2.4  0.6 g/L; P  .05
extracorporeal circulation vs all others) and red blood cell damage (free Hb:
extracorporeal circulation, 16.8 11.4 mol/L; uncoated extracorporeal circulation
with shed blood separation, 10.3  3.5 mol/L; coated extracorporeal circulation
with shed blood separation, 6.8  2.9 mol/L; no extracorporeal circulation, 3.4 
1.1 mol/L; P  .05 extracorporeal circulation vs no extracorporeal circulation,
coated extracorporeal circulation with shed blood separation). Coated extracorpo-
real circulation with shed blood separation showed only slight activation and cell
trauma, which did not differ significantly from no extracorporeal circulation.
Conclusions: Combination of coating and avoidance of shed blood recirculation
maintained physiological coagulation levels and markedly reduced red blood cell
trauma in extracorporeal circulation procedures. These combined modalities may
therefore offer an alternative for off-pump procedures in patients with contraindi-
cations for conventional extracorporeal circulation.
Extracorporeal circulation modalities induce a systemic inflammatoryresponse.1 The complex pathomechanism is still not entirely under-stood. However, a variety of humoral as well as cellular reactionshas been identified thus far.1 Among these, mechanical alteration ofcorpuscular blood elements as well as humoral response due to thecontact of the blood with foreign surfaces and mechanical propelling
devices are considered to be significant contributors.1-3 Furthermore, the duration of
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extracorporeal circulation and the degree of activation ex-
hibit a direct correlation.4 Humoral and cellular factors can
interact in a complex fashion by means of complement
activation, induction of arachidonic acid metabolism, cyto-
kine liberation, and initiation of coagulation-fibrinolytic
cascades.1-5 Much effort was undertaken in recent years to
reduce the damage caused by the heart-lung machine.3 The
first success was achieved by means of coating of the
involved components such as tubes, reservoir, and oxygen-
ator.6 Among the recent developments, a phosphorylcholine
surface coating showed promising results and was therefore
clinically introduced.7 Evidence showed that inflammatory
agents develop in shed blood accumulated during cardiac
procedures, which may well be able to enhance the inflam-
matory response when recirculated into the extracorporeal
circuit.4,8,9 Therefore, a shed blood separation system im-
plemented in a cardiotomy reservoir was developed to avoid
direct recirculation. The purpose of this study was to eval-
uate the potential of phosphorylcholine coating and shed
blood separation to reduce activation of coagulation-fibrino-
lytic cascades as one of the components of the inflammatory
response during cardiac procedures, utilizing an otherwise
conventional extracorporeal circulation system.
Material and Methods
Demographic Data
Forty patients (62  10 years) underwent isolated elective coro-
nary revascularization for single-, double-, or triple-vessel disease.
All patients had sinus rhythm and a preoperative ejection fraction
of more than 35% and all exhibited normal renal and hepatic
function (serum creatinine  100 mol/L; prothrombin time 
70%). None of the patients was on anticoagulatory medication
with coumarin, and all patients received chronic medication with
acetylsalicylic acid until 7 days preoperatively (100 mg daily
dose).
Operation
The patients were operated on according to clinical and morpho-
logical criteria. Conventional coronary revascularization with car-
diopulmonary bypass (CPB) was performed for double- or triple-
vessel disease. Minimally invasive arterial revascularization
(MIDCAB) without CPB was performed in patients with single-
vessel disease. In all CPB patients the left internal thoracic artery
and a respective number of vein grafts/anastomoses were used. All
patients operated on with CPB underwent total median sternotomy,
preparation, and harvesting of the left internal thoracic artery after
the pleura was opened, combined with conventional open venous
harvesting. In all MIDCAB patients the left internal thoracic artery
was prepared via a left anterior thoracotomy and was anastomosed
to the LAD with mechanical stabilization while the heart was
beating.
Study Protocol
The study protocol was approved by the local ethical committee on
human research. All patients who agreed to participate in this trial
gave written informed consent. The patients with double- or triple-
vessel disease were randomly allocated to 1 of the CPB groups.
The patients with single-vessel disease were uniformly allocated to
the MIDCAB group. Four groups (n  10) were defined: noECC,
MIDCAB; ECC, conventional extracorporeal circulation without
coating and shed blood separation; ECCSBS, uncoated ECC with
shed blood separation system; CECCSBS, coated ECC with shed
blood separation system.
Anesthesia
All patients received general anesthesia, conventional intubation,
and ventilation. MIDCAB patients received a double lumen tra-
cheobronchial tube to perform intermittent unilateral ventilation.
After premedication with benzodiazepine, general anesthesia was
induced and maintained with propofol, skeletal muscle relaxation
with pancuronium bromide, and volatile anasthetics (isoflurane).
Standard monitoring was established. Prior to institution of CPB
all patients received 400 IU/kg of body weight (BW) intravenous
heparin and additional doses, if required, to maintain an activated
clotting time (ACT) of over 400 seconds during CPB. ACT (au-
tomated coagulation timer ACT II; Medtronic HemoTec Inc,
Englewood, NJ) was measured directly after initial heparin admin-
istration and every 20 minutes thereafter until the end of the
procedure. Volatile anesthetics (Sevoflurane; Dra¨ger AG, Bremen,
Germany) were given via the heart-lung machine during extracor-
poreal circulation. MIDCAB patients received 100 mg/kg BW
heparin intravenously after left internal thoracic artery preparation.
After completion of the anastomosis heparin was partially antag-
onized with 50 mg/kg BW protamine.
General Extracorporeal Circulation Modalities
Extracorporeal circulation modalities (Sto¨ckert SIII, Sto¨ckert In-
struments, Munich, Germany) comprised 3-point pressure moni-
toring (pre- and postoxygenator, arterial line; x-trans; Smith Med-
ical Inc, Kirchseeon, Germany) and online blood gas analysis (CDI
500; Terumo CVSE Inc, Borken, Germany). Priming consisted of
900 mL Ringer’s solution, 400 mL HES 6% (poly(O-2-hydroxy-
ethyl-starch), 250 mL mannitol, 10000 U heparin, 2 million U
aprotinin, and 20 mL NaHCO3. Extracorporeal circulation was
instituted in all patients via a 24F central aortic cannula (Jostra
AG, Hirrlingen, Germany), a central 2-stage venous cannula 50/
36-French (Sto¨ckert Instruments), and a main circulatory roller
pump (Sto¨ckert Instruments). The blood was drained into a car-
diotomy reservoir (AVANT Reservoir D970; Dideco Inc, Miran-
dola, Italy), pumped through a conventional oxygenator (AVANT-
Oxygenator, Dideco Inc), and filtered (D734, Dideco Inc) back
into the patient at a rate of 2.5 L/min/m2 body surface area. Shed
blood suction was performed with a roller pump (Sto¨ckert Instru-
ments). Moderate hypothermia of 33° to 34°C was employed. A
regular vacuum suction was additionally used to clear the opera-
tive field. The system consisted of a disposable suction cannula
and tube connected with a sterile heparinized chamber. The aspi-
rated blood was processed in a cell saver, and debris and fat were
removed by an integrated 200-m filter (Compact A 75173,
Dideco Inc). Electrical fibrillation was applied and the aorta was
crossclamped. Antegrade cold blood cardioplegia (blood cardio-
plegia “Buckberg,” cardioplegia systems with “CSC14,” Dideco
Inc) mixed from buffer solution and autologous blood circulating
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in the CPB was delivered via a roller pump and a heat exchanger
at 4°C. After revascularization weaning from CPB was performed
in the typical fashion. Thereafter, all patients received 1:1 prota-
mine to antagonize heparin. The thorax was closed and the patient
was transferred to the intensive care unit (ICU). The erythrocytes
processed in the cell saver were substituted directly after arrival on
the ICU. Drainage loss was measured using the calibration of a
closed evacuation system (PLEUR-EVAC Sahara; Genzyme
GmbH, Neu-Isenburg, Germany).
Specific Extracorporeal Circulation Modalities
Shed blood separation used in the ECCSBS group as well as in the
CECCSBS group was performed with the aforementioned cardiot-
omy reservoir (AVANT D970). The simple system consists of a
reservoir with a separation chamber positioned on top of the main
chamber. Sucked blood is drained into the separation chamber and
runs freely through it into the main chamber as long as separation
is not desired. If separation is indicated, the connecting tube is
mechanically closed so that the blood remains in the separation
chamber (Figure 1). In case of an acute volume demand the
connecting tube can be reopened at any time, which was not
necessary in the study. After weaning from CPB the separated shed
blood was processed in a cell saver together with conventionally
aspirated blood from the operating field. In the CECCSBS group a
tip-to-tip coating of all components was used comprising a phos-
phorylcholine (PHISIO, Dideco, Inc) coating of all tubes as well as
the cannulas, oxygenator, and filter.
Postoperative Therapy
Weaning from ventilation was performed within the following 6 to
12 hours. The patients were then transferred from the ICU to the
normal ward. Changes in electrocardiogram and myocardial en-
zymes were frequently monitored to detect perioperative myocar-
dial infarction. All patients operated on with CPB remained in the
hospital for 12 to 18 days while MIDCAB patients remained for 5
to 8 days.
Laboratory Assessment
In all extracorporeal circulation groups arterial blood was drawn at
5 time points: preoperatively, intraoperatively (after institution of
CPB, after crossclamp release, directly after decannulation), and
postoperatively (first postoperative day). In the noECC group
blood was drawn at 3 time points (preoperatively, intraoperatively,
and first postoperative day). Free hemoglobin was determined
photometrically. Hemoglobin, erythrocyte count, and platelet
count were analyzed with the automated Hematology Analyser
K-500 (Sysmex, Norderstedt, Germany). For verification of plate-
let function von Willebrand factor in the plasma of the patients was
tested against lyophilized donor platelets while ristocetin was
added as an activator. Ristocetin-cofactor activity was analyzed
with a commercially available agglutination test (Behring Coagu-
lation Timer; Dade Behring, Marburg, Germany). The activity was
described as percentage of normal activity obtained with pooled
donor plasma.10,11 The coagulation parameters thrombin-anti-
thrombin complex (TATc) and prothrombin fragments 1 and 2
(F12) and the fibrinolysis parameter plasmin-antiplasmin com-
Figure 1. Shed blood separation system: schematic view of the shed blood separation system integrated in the
reservoir of the extracorporeal circulation. Note the switch (insert) provided to guarantee direct recirculation in
case of urgent volume demand. Upward movement of the column results in drainage of separated blood
accumulated in the upper chamber into the conventional reservoir (lower chamber).
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plex (PAPc) were analyzed by means of commercially available
standard enzyme-linked immunosorbent assay techniques (TATc:
Enzygnost thrombin-antithrombin complex micro; PAPc: Enzyg-
nost plasmin/2-antiplasmin complex micro, F12: Enzygnost
prothrombin fragment 1 and 2, Dade Behring, Marburg, Ger-
many).
Statistical Analysis
Statistical analysis was performed using SPSS statistical package
for Windows (Version 9.0, SPSS Inc, Chicago, Ill). Numeric
variables with normal distribution were analyzed by means of
analysis of variance (ANOVA) and post hoc comparisons with
Tukey honestly significant difference adjustment. Non-normally
distributed variables were analyzed by means of Kruskal-Wallis
test and subsequent Mann-Whitney test. Categorical variables
were analyzed by means of Pearson chi-square test and subsequent
 adjustment. Data are shown as mean percentages or means 
standard deviation (SD). Significance was assumed if P  .05.
ANOVA/Kruskal-Wallis test P values are shown or t test/Mann-
Whitney test P values between specific groups are presented,
respectively.
Results
Demographic and Operative Data
The majority of the patients were male (n  38). Patients
who underwent a MIDCAB procedure (noECC) tended to
be younger and appeared to have less comorbidities as
assessed by EuroSCORE than the other cohorts, although
the differences did not gain statistical significance. All pa-
tients had an uneventful postoperative course. Rethora-
cotomy for bleeding was necessary in 2 patients (1 in ECC
group, 1 in CECCSBS group). None of the patients devel-
oped a postoperative myocardial infarction. Sternal refix-
ation because of dehiscence was necessary in 1 patient
(ECCSBS group). Transient, mild psychosis was seen in 5
of the patients (2 in ECC group, 2 in ECCSBS group, 1 in
CECCSBS group). Major neurological events such as focal
deficits did not occur. Hospitalization of the noECC patients
was significantly shorter than in all other groups, although
differences between the 3 groups operated upon with CPB
were not observed (Table 1).
Hematological Parameters
In all groups preoperative mean erythrocyte count did not
show significant differences. In all CPB groups erythrocyte
count decreased significantly compared with noECC during
extracorporeal circulation and remained decreased at the
first postoperative day. Significant differences between the
3 CPB groups were not observed. Free hemoglobin in-
creased during operation in all CPB groups, although it
remained rather stable in the noECC group. However, both
shed blood separation groups showed significantly lower
levels than the conventional ECC group, while not differing
significantly from the noECC group. Between CECCSBS
and ECCSBS groups no significant differences were de-
tected, although the lowest values were observed at the end
of the operation in the CECCSBS group. Postoperatively,
the values of all patients in the CPB group normalized
without showing significant differences compared with no-
ECC group, while in both ECCSBS and ECC groups the
values were higher than in noECC and CECCSBS groups
(Table 2).
Platelet Count and Function
In all groups including the noECC patients platelets de-
creased intraoperatively and remained lower than prior to
operation at the first postoperative day. No significant dif-
ferences were found between all 4 groups. Ristocetin-co-
factor increased in both uncoated ECC groups during CPB
and remained elevated postoperatively, whereas the noECC
group remained entirely stable and the coated ECCSBS
group showed only slight alterations. However, because of
a rather high variance these differences did not gain statis-
tical significance at the 5% level (Table 3).
Coagulation and Fibrinolysis Parameters
TATc did not increase in the noECC group but increased in
all extracorporeal circulation groups. However, distinct dif-
ferences were found between all 3 CPB groups. Although
ECC and ECCSBS groups showed a marked increase
throughout the CPB period, an only moderate increment
TABLE 1. Demographic data
Patients noECC ECC ECCSBS CECCSBS P values
Age (years) 54.3 14.1 64.1 12.1 61.3 11.2 60.3 7.9 NS (.299)
Involved vessels (no.) 1.2 0.4 2.7 0.5 2.7 0.5 2.7 0.7 .001
BMI 26 8 27 4 27 3 26 3 NS
EF (%) 59 16 62 12 61 11 61 12 NS
EuroSCORE 2.6 2.2 4.2 2.6 4.6 1.8 3.3 3.3 NS (.331)
Distal anastomoses (no.) 1 3.1 1.4 3.7 0.8 3.8 0.8 .001
Bypass time (min) — 90 36 98 18 97 23 NS
Cross-clamping-time (min) — 50 21 47 13 56 15 NS
ICU stay (days) 1.1 0.3 1.6 1.4 1.4 0.5 1.5 0.9 NS
Hospitalization (days) 6.4 1.5 15.8 2.6 16.8 2.6 15.7 3.3 .001
BMI, Body mass index; EF, left ventricular ejection fraction; ICU, intensive care unit; NS, not significant.
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was observed in the CECCSBS group. The ECC group
revealed the highest levels at the time points after cross-
clamp release and after weaning from CPB, differing sig-
nificantly from both ECCSBS and CECCSBS groups. At
the first postoperative day the observed differences disap-
peared (Table 4, Figure 2).
F12 increased in both ECC and ECCSBS groups dur-
ing extracorporeal circulation, while the values remained
stable in noECC and CECCSBS groups. The ECC group,
however, showed markedly increased peak levels differing
from noECC group, CECCSBS group, and also from
ECCSBS group. At the end of CPB CECCSBS and
ECCSBS groups also showed statistical differences while
no differences were found between noECC and CECCSBS
groups. At the first postoperative day the values had nor-
malized (Table 4).
PAPc exhibited corresponding findings. Although no in-
crease was found in the noECC group as well as in the
CECCSBS group, the ECC and ECCSBS groups reacted
significantly with the time course of the CPB, whereas no
statistical difference was found between ECC and ECCSBS
groups. Postoperatively, the differences diminished (Table
4, Figure 3).
Drainage Loss: Blood and Blood Product Substitution
In the noECC group the least amount of postoperative
drainage loss was observed. All CPB groups exhibited a
higher amount of drainage fluid without showing significant
differences. In the noECC group the least cumulative
amounts of blood and fresh-frozen plasma units were sub-
stituted, although statistical differences with the CPB
groups were not found (Table 5).
Discussion
Extracorporeal Circulation
Alteration of corpuscular elements of the blood during
extracorporeal circulation is well recognized.12 A variety of
factors such as shear stress, nonbiological surface contact,
and temperature contribute to this phenomenon, which in-
creases with extracorporeal circulation time.3,4 As early as
TABLE 2. Hematological parameters
Preoperative
Intraoperative, after
CPB institution
Intraoperative, after
crossclamp release
Intraoperative, after
decannulation
First postoperative
day
Erythrocytes (T/I)
NoECC 4.7 0.3 3.8 0.4 3.9 0.2
ECC 4.3 0.7 3.3 1.0* 2.9 0.7* 2.7 0.6* 3.0 0.3*
ECCSBS 4.5 0.6 3.0 0.9* 2.7 0.4* 2.8 0.5* 2.9 0.3*
CECCSBS 4.7 0.6 3.3 1.0* 2.9 0.7* 2.7 0.6* 3.0 0.3*
fHb (mol/L)
NoECC 2.9 1.4 3.4 1.1† 3.5 0.8
ECC 4.0 5.7 13.3 10.9 18.1 8.3 16.8 11.4 6.4 5.8
ECCSBS 5.0 1.1 5.8 4.2† 8.7 4.2† 10.3 3.5 6.2 1.2
CECCSBS 4.5 6.3 5.3 3.4† 7.8 4.5† 6.8 2.9† 4.2 2.3
CPB, Cardiopulmonary bypass; fHb, free hemoglobin; NS, not significant.
*P  .05 vs No ECC group.
†P  .05 vs ECC group.
TABLE 3. Platelet count and function
Preoperative
Intraoperative, after
CPB institution
Intraoperative, after
clossclamp release
Intraoperative, after
decannulation
First postoperative
day
Platelets (G/I)
noECC 238 86 195 107 181 60
ECC 210 57 152 53 139 52 120 36 177 127
ECCSBS 210 70 161 73 158 64 121 42 142 49
CECCSBS 231 84 165 60 171 70 147 58 158 42
Ristocetin cofactor (%)
noECC 153 58 154 67 141 71
ECC 196 85 146 80 163 61 242 127 260 96*
ECCSBS 142 57 95 41 111 49 174 76 218 71
CECCSBS 153 65 112 47 123 58 147 55† 185 66
CPB, Cardiopulmonary bypass. Ristocetin cofactor activity given in percent of the normal activity.
*P  .128 vs NoECC group.
†P  .119 vs ECC group.
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1979, however, cardiotomy suction has been identified to
enhance cellular damage.13 Later, however, it was shown
that red cell deformability, which was supposed to be the
consequence of a mechanical trauma, was not caused by
extracorporeal circulation itself but rather by mediators
accumulated during prolonged blood pooling.14 It was
instead shown that platelets and leukocytes are more
likely to be damaged by mere mechanical forces such as
roller or centrifugal pumps.12,15 Parallel to the investiga-
tions regarding the mechanical trauma many studies fo-
cused on the effect of CPB on the activation of coagulation
cascades.16 It could be clearly shown that coagulopathy was
TABLE 4. Coagulation and fibrinolytic parameters
Preoperative
Intraoperative, after
CPB institution
Intraoperative, after
crossclamp release
Intraoperative, after
decannulation
First postoperative
day
TATc (g/L)
NoECC 2.5 1.5 2.4 0.6† 6 2.6
ECC 6.1 4.7 16.4 12.5 23.7 19.5 31.1 15.8 5.8 2.4
ECCSBS 4.6 3.5 7.3 9.8*,† 6.1 4.1† 15.3 7.8†,‡ 9.8 4.2
CECCSBS 2.9 1.5 2.8 1.2* 2.8 1.0† 8.1 4.8† 6.5 3.7
Prothrombin fragments 1 and 2 (nmol/L)
NoECC 1.7 0.5 1.6 0.5 1.7 0.7
ECC 1.4 0.6 1.9 0.6 2.7 1.0* 3.9 1.0* 1.3 0.4
ECCSBS 1.7 0.6 1.5 0.6 1.6 0.6† 2.6 1.1†,** 2.0 0.7
CECCSBS 1.5 0.9 0.9 0.5† 0.9 0.4† 1.2 0.4†,§ 1.4 1.4
PAPc (g/L)
NoECC 275 128 253 99 262 174
ECC 337 148 309 183 895 832 898 367* 159 128
ECCSBS 434 213 442 326 1317 1092* 1098 665* 351 577
CECCSBS 227 111 190 100§§ 292 192§ 250 154†,§ 116 56
CPB, Cardiopulmonary bypass, TATc, thrombin-antithrombin complex; PAPc, plasmin-antiplasmin complex.
*P  .05 vs NoECC group.
**P  .085 vs NoECC group.
†P  .05 vs ECC group.
‡P  .07 vs ECC group.
§P  .05 vs ECCSBS group.
§§P  .055 vs ECCSBS group.
Figure 2. Thrombin-antithrombin complex (g/L) of the noECC,
ECC, ECCSBS, and CECCSBS groups. Data obtained at the 5 time
points: preoperatively (preop.), intraoperatively after CPB institu-
tion (at CPB), after crossclamp release (after x-clamp), after
decannulation (after CPB), at the first postoperative day (PO day
1). Data are presented as mean  SD.
Figure 3. Plasmin-antiplasmin complex (g/L) of the noECC, ECC,
ECCSBS, and CECCSBS groups. Data obtained at the 5 time points:
preoperatively (preop.), intraoperatively after CPB institution (at
CPB), after crossclamp release (after x-clamp), after decannula-
tion (after CPB), at the first postoperative day (PO day 1). Data are
presented as mean  SD.
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mediated by extracorporeal circulation and its time
course.17 Much effort has been undertaken to reduce the
mechanical stress as well as the coagulation activation dur-
ing CPB.18
Coating
Several investigators have focused on a coating system of
the CPB components to disguise the foreign surface. As a
consequence, different modalities have evolved.6,7 Heparin
coating appeared to be a reasonable option, although most
recent results were not entirely encouraging.19,20 As an
alternative, a phosphorylcholine coating was developed. It
is considered to mimic the biological endothelial surface
because phosphorylcholine is an integral component of the
cell membrane.7 The first studies indeed showed positive
effects of such a coating. Therefore, phosphorylcholine
coating has been clinically introduced.7
Shed Blood Recirculation
It was observed that suction of pooled pleural blood into the
cardiotomy reservoir and its recirculation resulted in a va-
riety of detrimental effects. Liberation of prostacyclin and
prostaglandin E2 in shed blood resulted in a marked de-
crease of the systemic blood pressure after recirculation.8
Other detrimental effects of shed blood have been identified
as induced by lipid microembolization,21 activated comple-
ment,22 or cytokine release of pooled leukocytes.23 The
important clinical consequence of an increased postopera-
tive blood loss because of an activation of fibrinolysis and
platelet dysfunction in shed blood has already been demon-
strated.24 Therefore, avoidance of shed blood recirculation
has been propagated to minimize these effects. Unfortu-
nately, the amount of blood drained from the operating field
can be high. A considerable loss of autologous blood there-
fore occurs. As an avenue out of this dilemma, a shed blood
separation system was developed. The separated shed blood
can be processed in a cell saver to retrieve the red blood
cells for subsequent administration while potentially detri-
mental humoral factors are eliminated.1,5,21-23
Study
In summary of the literature, both coating and shed blood
separation appeared to be beneficial in terms of a reduction
of cellular alteration and humoral activation. We therefore
conducted a clinical study to elucidate these effects. As a
control, we chose a MIDCAB instead of an off-pump cor-
onary artery bypass (OPCAB) procedure because it repre-
sents an off-pump coronary revascularization technique
with a minor operative trauma. Because a median sternot-
omy was not performed, liberation of bone marrow fat and
subsequent activation of inflammatory parameters such as
cytokines or arachidonic acid metabolites was avoided. Oth-
erwise, MIDCAB patients exhibited sufficient similarities
with the other groups because they suffered from arterio-
sclerosis, underwent almost identical anesthesia, and re-
ceived acetylsalicylic acid as well as heparin and protamine.
All ECC patients were submitted to a standard low-dose
aprotinin protocol. A recent study showed that low-dose
aprotinin did not inhibit the inflammatory response and
coagulation caused by cardiopulmonary bypass as assessed
by TATc. A reduction of fibrinolyis assessed by PAPc,
however, was observed.25
Red Blood Cells
In our study we found supporting evidence for the data
published in the literature as well as both investigated
strategies. The global erythrocyte count decreased only
moderately in all CPB groups. Free hemoglobin, in contrast,
was markedly increased in the conventional ECC group
while it was much less elevated in both shed blood separa-
tion groups. The combination of coating and shed blood
separation, however, exhibited the least damage.
Platelets
In our study we did not find statistical proof for an effect of
shed blood separation and coating on platelet morphology
and function. However, some trends were observed and can
be interpreted carefully in the light of the results already
demonstrated in the literature. The total number of platelets
did not exhibit significant findings aside from a moderate
decrease in all groups including the MIDCAB patients,
although we expected a normal platelet count in our MID-
CAB procedures because of the absence of CPB and the
moderate blood loss. Von Willebrand factor–ristocetin co-
factor correlates with platelet aggregation in high shear
stress situations such as extracorporeal circulation10,11 and
was therefore chosen to assess platelet function in this
study. Indeed, platelet function appeared to be less altered in
the coated CPB group. One could therefore assume a ben-
TABLE 5. Drainage loss; blood and blood product substitution
Patients noECC ECC ECCSBS CECCSBS P value
Drainage loss (mL) 446 222 666 154 639 151 683 258 NS (.069)
Blood units (U) 0.7 0.9 1.1 1.9 1.3 2.4 0.7 1.0 NS
FFP (U) 0.4 1.3 0.7 1.0 0.3 0.6 0.8 1.9 NS
FFP, Fresh-frozen plasma; NS, not significant.
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eficial effect of phosphorylcholine coating on platelet func-
tion, which has already been demonstrated by others.7 Hep-
arin alone and in combination with protamine can alter
platelet function and induce fibrinolysis,26 although chronic
pretreatment with acetylsalicylic acid may have reduced this
phenomenon in our study. However, our findings supported
the hypothesis that platelet consumption by activation, ag-
gregation, and clearance can be triggered by the various
drug interactions during anesthesia.1
Coagulation and Fibrinolysis
The analysis of coagulatory and fibrinolysis parameters
exhibited a detrimental effect of conventional extracorpo-
real circulation. In conventional ECC both coagulation and
fibrinolysis were markedly elevated, although shed blood
separation alone was beneficial in terms of a reduction of
coagulation disturbances but not fibrinolysis. The combina-
tion of coating and shed blood separation was followed by
the least pronounced effects of coagulation and fibrinolysis
in our study. We expected a down-regulation of fibrinolysis
in all ECC groups because of the standard low-dose apro-
tinin protocol, which was uniformly applied.25 The remain-
ing extent of fibrinolysis in both uncoated groups, however,
underlines the benefit of coating with phosphorylcholine in
terms of a reduction of fibrinolysis. In this regard one can
speculate that in the coated groups a reduction of circulating
fibrin monomers may have contributed to a partial neutral-
ization of plasmin activity.
Blood Loss and Substitution
One of the important clinical consequences of a reduced
activation of coagulation cascades, as well as alteration of
blood cells due to mechanical forces, may be the amount of
perioperative drainage as well the necessity for blood and
blood product substitution.26 Our results demonstrated that
drainage loss was higher in all CPB groups than in the
MIDCAB patients. However, statistical evidence was not
seen. Both the MIDCAB patients as well as the group with
shed blood separation and coating required less substitution
of blood than the other CPB groups. Again, these differ-
ences did not reach statistical significance.
Study Limitations
In our study the isolated impact of phosphorylcholine coat-
ing was not investigated. Other clinical studies, however,
have already been conducted and exhibited positive effects
of phosphorylcholine coating on coagulation.6,7 The specific
CPB modalities investigated by us did not serve the purpose
of saving blood in our study, although the observed trends
may gain statistical relevance in a larger trial.
Conclusion
We conclude from this first investigation that phosphoryl-
choline coating in combination with shed blood separation
reduced mechanical alteration of red blood cells and coag-
ulation disturbances in routine CPB procedures to a level
otherwise only seen in off-pump procedures. The separated
blood can be processed in a cell saver for later substitution,
thereby avoiding excessive blood loss.
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